Production of drug molecular building blocks including non-natural amino acids, protected amino acids, nucleoside blocks, chiral blocks, and heterocyclic blocks at milligram to kilogram scale.

Production of pharmaceutical intermediates including chiral intermediates, antiviral drug intermediates, and intermediates for peptide and peptidomimetic APIs with custom manufacturing capabilities.